相关实验视频

Updated: Jul 17, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

针对非小细胞肺癌的新辅助免疫疗法:机遇和挑战

Junjie Hu¹, Jing Zhang², Shiyue Wan³

¹School of Medicine, Tongji University, Shanghai 200092, China.

Chinese medical journal pulmonary and critical care medicine

|January 21, 2025

概括

新辅助免疫疗法,包括免疫检查点抑制剂 (ICI),对可切除的非小细胞肺癌显示出希望,改善了生存率. 挑战包括识别生物标志物和克服对个性化治疗的抵抗.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
癌症研究癌症研究

背景情况:

免疫检查点抑制剂 (ICI) 已经彻底改变了可切除的非小细胞肺癌 (NSCLC) 治疗.
新辅助免疫疗法越来越多地被用于早期NSCLC,显示安全性和有效性.

研究的目的:

对可切除NSCLC的新辅助免疫疗法方案进行I-III期临床试验的审查.
讨论各种新辅助方法的好处,结果和挑战.

主要方法:

对I-III期临床试验进行系统审查.
对新辅助性ICI单疗法,组合疗法 (化疗,抗血管生成药物,双重ICI,放射治疗) 的分析.
检查瘤微环境 (TME) 特性和T细胞反应.

主要成果:

新辅助免疫疗法显示出显著的疗效,高的病理反应率,以及在NSCLC中改善无事件生存率.
各种疗法,包括ICI单疗法和组合疗法,显示出有前途的结果.
瘤微环境动态和T细胞反应对于治疗疗效至关重要.

结论:

新辅助免疫疗法为可切除的NSCLC提供了一个有前途的治疗策略.
应对生物标志物识别,治疗持续时间和耐药性机制等挑战至关重要.
未来的研究应该专注于个性化方法和理解TME重塑以获得更好的结果.

关键词:

生物标志物生物标志物组合疗法是一种组合疗法.肺癌是一种肺癌.新辅助免疫疗法新辅助免疫疗法瘤微环境是一个微环境.

更多相关视频

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...